Novartis looks set to buy US-based The Medicines Company in a US$9 billion deal that will see the Swiss company acquire rights to the world's first RNAi therapeutic for lowering cholesterol. …
Latest Video
New Stories
-
The Finance portfolio almost always calls the Senate home
July 6, 2020 - - Latest News -
High 'continuation' rate could mean a cascading price cut
July 6, 2020 - - Latest News -
How many new patients are even left in the migraine subsidy cap?
July 6, 2020 - - Latest News -
MSD: Disappointed over no 'right of reply'
July 6, 2020 - - Latest News -
Roche general manager Stuart Knight on 'transformation'
July 6, 2020 - - Latest News -
COVID-19: Pfizer the latest to announce positive vaccine data
July 3, 2020 - - Latest News -
COVID-19: Positive news on Affinity Biosciences antibodies
July 3, 2020 - - Latest News